Disparate roles of ATR and ATM in immunoglobulin class switch recombination and somatic hypermutation

Journal of Experimental Medicine

Volumn 203, Issue 1, 2006, Pages 99-110

  Pan Hammarström, Qiang ^a   Lähdesmäki, Aleksi ^a   Zhao, Yaofeng ^a   Du, Likun ^a   Zhao, Zhihui ^a   Wen, Sicheng ^a   Ruiz Perez, Victor L ^b   Dunn Walters, Deborah K ^c   Goodship, Judith A ^b   Hammarström, Lennart ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATR PROTEIN; DNA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ARTICLE; BLOOD; CASE REPORT; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENE SWITCHING; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC HYPERMUTATION;

CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; HUMANS; IMMUNOGLOBULIN ALPHA-CHAINS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN GAMMA-CHAINS; IMMUNOGLOBULIN MU-CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MUTATION; PROTEIN-SERINE-THREONINE KINASES; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TUMOR SUPPRESSOR PROTEINS;

EID: 31344465936     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20050595     Document Type: Article

References (69)

1. Lieber, M.R., Y. Ma, U. Pannicke, and K. Schwarz. 2003. Mechanism and regulation of human non-homologous DNA end-joining. Nat. Rev. Mol. Cell Biol. 4:712-720.
2. Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 102:553-563.
3. Di Noia, J., and M.S. Neuberger. 2002. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature. 419:43-48.
4. Rada, C., G.T. Williams, H. Nilsen, D.E. Barnes, T. Lindahl, and M.S. Neuberger. 2002. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 12:1748-1755.
5. Petersen-Mahrt, S.K., R.S. Harris, and M.S. Neuberger. 2002. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature. 418:99-103.
6. Chaudhuri, J., and F.W. Alt. 2004. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol. 4:541-552.
7. Savitsky, K., A. Bar-Shira, S. Gilad, G. Rotman, Y. Ziv, L. Vanagaite, D.A. Tagle, S. Smith, T. Uziel, S. Sfez, et al. 1995. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 268:1749-1753.
8. Lähdesmäki, A., K. Arinbjarnarson, J. Arvidsson, M.E. Segaier, A. Fasth, E. Fernell, D. Gustafsson, V.-A. Oxelius, K. Risberg, J. Yuen, et al. 2000. Ataxia-telangiectasia surveyed in Sweden. [In Swedish.] Lakartidningen. 97:4461-4467.
9. Pan, Q., C. Petit-Frere, A. Lähdesmäki, H. Gregorek, K.H. Chrzanowska, and L. Hammarström. 2002. Alternative end joining during switch recombination in patients with ataxia-telangiectasia. Eur. J. Immunol. 32:1300-1308.
10. Reina-San-Martin, B., H.T. Chen, A. Nussenzweig, and M.C. Nussenzweig. 2004. ATM is required for efficient recombination between immunoglobulin switch regions. J. Exp. Med. 200:1103-1110.
11. Lumsden, J.M., T. McCarty, L.K. Petiniot, R. Shen, C. Barlow, T.A. Wynn, H.C. Morse III, P.J. Gearhart, A. Wynshaw-Boris, E.E. Max, and R.J. Hodes. 2004. Immunoglobulin class switch recombination is impaired in Atm-deficient mice. J. Exp. Med. 200:1111-1121.
12. Petersen, S., R. Casellas, B. Reina-San-Martin, H.T. Chen, M.J. Difilippantonio, P.C. Wilson, L. Hanitsch, A. Celeste, M. Muramatsu, D.R. Pilch, et al. 2001. AID is required to initiate Nbs1/γ-H2AX focus formation and mutations at sites of class switching. Nature. 414:660-665.
13. Lähdesmäki, A., A.M. Taylor, K.H. Chrzanowska, and Q. Pan-Hammarström. 2004. Delineation of the role of the Mre11 complex in class switch recombination. J. Biol. Chem. 279:16479-16487.
14. Reina-San-Martin, B., M.C. Nussenzweig, A. Nussenzweig, and S. Difilippantonio. 2005. Genomic instability, endoreduplication, and diminished Ig class-switch recombination in B cells lacking Nbs 1. Proc. Natl. Acad. Sci. USA. 102:1590-1595.
15. Kracker, S., Y. Bergmann, I. Demuth, P.O. Frappart, G. Hildebrand, R. Christine, Z.Q. Wang, K. Sperling, M. Digweed, and A. Radbruch. 2005. Nibrin functions in Ig class-switch recombination. Proc. Natl. Acad. Sci. USA. 102:1584-1589.
16. Reina-San-Martin, B., S. Difilippantonio, L. Hanitsch, R.F. Masilamani, A. Nussenzweig, and M.C. Nussenzweig. 2003. H2AX is required for recombination between immunoglobulin switch regions but not for intra-switch region recombination or somatic hypermutation. J. Exp. Med. 197:1767-1778.
17. Manis, J.P., J.C. Morales, Z. Xia, J.L. Kutok, F.W. Alt, and P.B. Carpenter. 2004. 53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination. Nat. Immunol. 5:481-487.
18. Ward, I.M., B. Reina-San-Martin, A. Olaru, K. Minn, K. Tamada, J.S. Lau, M. Cascalho, L. Chen, A. Nussenzweig, F. Livak, et al. 2004. 53BP1 is required for class switch recombination. J. Cell Biol. 165:459-464.
19. Rolink, A., F. Melchers, and J. Andersson. 1996. The SCID but not the RAG-2 gene product is required for Sμ-Sε heavy chain class switching. Immunity. 5:319-330.
20. Manis, J.P., D. Dudley, L. Kaylor, and F.W. Alt. 2002. IgH class switch recombination to IgG1 in DNA-PKcs-deficient B cells. Immunity. 16:607-617.
21. Abraham, R.T. 2001. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15:2177-2196.
22. de Klein, A., M. Muijtjens, R. van Os, Y. Verhoeven, B. Smit, A.M. Carr, A.R. Lehmann, and J.H. Hoeijmakers. 2000. Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice. Curr. Biol. 10:479-482.
23. Brown, E.J., and D. Baltimore. 2000. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 14:397-402.
24. Pan-Hammarström, Q., S. Dai, Y. Zhao, I.F. van Dijk-Härd, R.A. Gatti, A.L. Børresen-Dale, and L. Hammarström. 2003. ATM is not required in somatic hypermutation of VH, but is involved in the in troduction of mutations in the switch μ region. J. Immunol. 170:3707-3716.
25. Bemark, M., J.E. Sale, H.J. Kim, C. Berek, R.A. Cosgrove, and M.S. Neuberger. 2000. Somatic hypermutation in the absence of DNA-dependent protein kinase catalytic subunit (DNA-PK(cs)) or recombination-activating gene (RAG)1 activity. J. Exp. Med. 192:1509-1514.
26. O'Driscoll, M., V.L. Ruiz-Perez, C.G. Woods, P.A. Jeggo, and J.A. Goodship. 2003. A splicing mutation affecting expression of ataxia- telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat. Genet. 33:497-501.
27. Bobabilla-Morales, L., A. Corona-Rivera, J.R. Corona-Rivera, C. Buenrostro, T.A. Garcia-Cobian, E. Corona-Rivera, J.M. Cantu-Garza, and D. Garcia-Cruz. 2003. Chromosome instability induced in vitro with mitomycin C in five Seckel syndrome patients. Am. J. Med. Genet. A. 123:148-152.
28. Casper, A.M., S.G. Durkin, M.F. Arlt, and T.W. Glover. 2004. Chromosomal instability at common fragile sites in Seckel syndrome. Am. J. Hum. Genet. 75:654-660.
29. Hayani, A., C.R. Suarez, Z. Molnar, M. LeBeau, and J. Godwin. 1994. Acute myeloid leukaemia in a patient with Seckel syndrome. J. Med. Genet. 31:148-149.
30. Pan, Q., C. Petit-Frere, S. Dai, P. Huang, H.C. Morton, P. Brandtzaeg, and L. Hammarström. 2001. Regulation of switching and production of IgA in human B cells in donors with duplicated a1 genes. Eur. J. Immunol. 31:3622-3630.
31. Betz, A.G., M.S. Neuberger, and C. Milstein. 1993. Discriminating intrinsic and antigen-selected mutational hotspots in immunoglobulin V genes. Immunol. Today. 14:405-411.
32. Milstein, C., M.S. Neuberger, and R. Staden. 1998. Both DNA strands of antibody genes are hypermutation targets. Proc. Natl. Acad. Sci. USA. 95:8791-8794.
33. Rogozin, I.B., Y.I. Pavlov, K. Bebenek, T. Matsuda, and T.A. Kunkel. 2001. Somatic mutation hotspots correlate with DNA polymerase η error spectrum. Nat. Immunol. 2:530-536.
34. Shiloh, Y. 2003. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer. 3:155-168.
35. Shiloh, Y. 2001. ATM and ATR: networking cellular responses to DNA damage. Curr. Opin. Genet. Dev. 11:71-77.
36. Tibbetts, R.S., K.M. Brumbaugh, J.M. Williams, J.N. Sarkaria, W.A. Cliby, S.Y. Shieh, Y. Taya, C. Prives, and R.T. Abraham. 1999. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13:152-157.
37. Caporali, S., S. Falcinelli, G. Starace, M.T. Russo, E. Bonmassar, J. Jiricny, and S. D'Atri. 2004. DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system. Mol. Pharmacol. 66:478-491.
38. Cortez, D., S. Guntuku, J. Qin, and S.J. Elledge. 2001. ATR and ATRIP: partners in checkpoint signaling. Science. 294:1713-1716.
39. Wuerffel, R.A., J. Du, R.J. Thompson, and A.L. Kenter. 1997. Ig Sγ3 DNA-specifc double strand breaks are induced in mitogen-activated B cells and are implicated in switch recombination. J. Immunol. 159:4139-4144.
40. Faili, A., S. Aoufouchi, Q. Gueranger, C. Zober, A. Leon, B. Bertocci, J.C. Weill, and C.A. Reynaud. 2002. AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line. Nat. Immunol. 3:815-821.
41. Li, Z., C.J. Woo, M.D. Iglesias-Ussel, D. Ronai, and M.D. Scharff . 2004. The generation of antibody diversity through somatic hypermutation and class switch recombination. Genes Dev. 18:1-11.
42. Neuberger, M.S., J.M. Di Noia, R.C. Beale, G.T. Williams, Z. Yang, and C. Rada. 2005. Somatic hypermutation at A.T pairs: polymerase error versus dUTP incorporation. Nat. Rev. Immunol. 5:171-178.
43. Zou, L., and S.J. Elledge. 2003. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science. 300:1542-1548.
44. Chaudhuri, J., C. Khuong, and F.W. Alt. 2004. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets. Nature. 430:992-998.
45. Pan-Hammarström, Q., A.M. Jones, A. Lähdesmäki, W. Zhou, R.A. Gatti, L. Hammarström, A.R. Gennery, and M.R. Ehrenstein. 2005. Impact of DNA ligase IV on nonhomologous end joining pathways during class switch recombination in human cells. J. Exp. Med. 201:189-194.
46. Haber, J.E. 1999. Sir-Ku-itous routes to make ends meet. Cell. 97:829-832.
47. Pan, Q., and L. Hammarström. 1999. Targeting of human switch recombination breakpoints: implications for the mechanism of μ -γ isotype switching. Eur. J. Immunol. 29:2779-2787.
48. Schrader, C.E., J. Vardo, and J. Stavnezer. 2002. Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions. J. Exp. Med. 195:367-373.
49. Barreto, V.M., A.R. Ramiro, and M.C. Nussenzweig. 2005. Activationinduced deaminase: controversies and open questions. Trends Immunol. 26:90-96.
50. Bartrand, A.J., D. Iyasu, and G.S. Brush. 2004. DNA stimulates Mec1-mediated phosphorylation of replication protein A. J. Biol. Chem. 279:26762-26767.
51. Barr, S.M., C.G. Leung, E.E. Chang, and K.A. Cimprich. 2003. ATR kinase activity regulates the intranuclear translocation of ATR and RPA following ionizing radiation. Curr. Biol. 13:1047-1051.
52. Binz, S.K., A.M. Sheehan, and M.S. Wold. 2004. Replication protein A phosphorylation and the cellular response to DNA damage. DNA Repair (Amst.). 3:1015-1024.
53. Fang, Y., C.C. Tsao, B.K. Goodman, R. Furumai, C.A. Tirado, R.T. Abraham, and X.F. Wang. 2004. ATR functions as a gene dosage-dependent tumor suppressor on a mismatch repair-deficient background. EMBO J. 23:3164-3174.
54. Wang, Y., and J. Qin. 2003. MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation. Proc. Natl. Acad. Sci. USA. 100:15387-15392.
55. Zeng, X., D.B. Winter, C. Kasmer, K.H. Kraemer, A.R. Lehmann, and P.J. Gearhart. 2001. DNA polymerase η is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat. Immunol. 2:537-541.
56. Martomo, S.A., W.W. Yang, and P.J. Gearhart. 2004. A role for msh6 but not msh3 in somatic hypermutation and class switch recombination. J. Exp. Med. 200:61-68.
57. Faili, A., S. Aoufouchi, S. Weller, F. Vuillier, A. Stary, A. Sarasin, C.A. Reynaud, and J.C. Weill. 2004. DNA polymerase eta is involved in hypermutation occurring during immunoglobulin class switch recombination. J. Exp. Med. 199:265-270.
58. Mayorov, V.I., I.B. Rogozin, L.R. Adkison, and P.J. Gearhart. 2005. DNA polymerase η contributes to strand bias of mutations of A versus T in immunoglobulin genes. J. Immunol. 174:7781-7786.
59. Sale, J.E., and M.S. Neuberger. 1998. TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line. Immunity. 9:859-869.
60. Zhang, W., P.D. Bardwell, C.J. Woo, V. Poltoratsky, M.D. Scharff , and A. Martin. 2001. Clonal instability of V region hypermutation in the Ramos Burkitt's lymphoma cell line. Int. Immunol. 13:1175-1184.
61. Yu, K., F.T. Huang, and M.R. Lieber. 2004. DNA substrate length and surrounding sequence affect the activation-induced deaminase activity at cytidine. J. Biol. Chem. 279:6496-6500.
62. Pham, P., R. Bransteitter, J. Petruska, and M.F. Goodman. 2003. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature. 424:103-107.
63. Borglum, A.D., T. Balslev, A. Haagerup, N. Birkebaek, H. Binderup, T.A. Kruse, and J.M. Hertz. 2001. A new locus for Seckel syndrome on chromosome 18p11.31-q11. 2. Eur. J. Hum. Genet. 9:753-757.
64. Faivre, L., M. Le Merrer, S. Lyonnet, H. Plauchu, N. Dagoneau, A.B. Campos-Xavier, J. Attia-Sobol, A. Verloes, A. Munnich, and V. Cormier-Daire. 2002. Clinical and genetic heterogeneity of Seckel syndrome. Am. J. Med. Genet. 112:379-383.
65. Kilinc, M.O., V.N. Ninis, S.A. Ugur, B. Tuysuz, M. Seven, S. Balci, J. Goodship, and A. Tolun. 2003. Is the novel SCKL3 at 14q23 the predominant Seckel locus? Eur. J. Hum. Genet. 11:851-857.
66. Goodship, J., H. Gill, J. Carter, A. Jackson, M. Splitt, and M. Wright. 2000. Autozygosity mapping of a Seckel syndrome locus to chromosome 3q22. 1-q24. Am. J. Hum. Genet. 67:498-503.
67. Alderton, G.K., H. Joenje, R. Varon, A.D. Borglum, P.A. Jeggo, and M. O'Driscoll. 2004. Seckel syndrome exhibits cellular features demonstrating defects in the ATR-signalling pathway. Hum. Mol. Genet. 13:3127-3138.
68. Pan, Q., H. Rabbani, F.C. Mills, E. Severinson, and L. Hammarström. 1997. Allotype-associated variation in the human γ3 switch region as a basis for differences in IgG3 production. J. Immunol. 158:5849-5859.
69. Lefranc, M.P. 2001. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 29:207-209.